(Q43846957)

27 November 2017

title

Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients (English)

1 reference

27 November 2017

0 references

1 reference

Thogulava R Kannan

1

1 reference

27 November 2017

Abha Saxena

series ordinal

2

1 reference

27 November 2017

Sushma Bhatnagar

series ordinal

3

1 reference

27 November 2017

Asootosh Barry

series ordinal

4

1 reference

27 November 2017

publication date

1 January 2002

1 reference

Journal of Pain and Symptom Management

27 November 2017

published in

1 reference

27 November 2017

volume

23

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

60-65

1 reference

Successful treatment of postherpetic neuralgia with oral ketamine.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Oral ketamine therapy in the treatment of postamputation stump pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Ketamine hydrochloride in the treatment of phantom limb pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Comparison of caudal bupivacaine and diamorphine with caudal bupivacaine alone for repair of hypospadias.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Assessment and treatment of neuropathic cancer pain following WHO guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Pharmacokinetics and analgesic effect of ketamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Interaction of Ketamine and Halothane in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Clinical experience with oral ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Comparison of morphine and morphine with ketamine for postoperative analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Low-dose ketamine infusion for analgesia during postoperative ventilator treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900373-6

7 January 2021

10.1016/S0885-3924(01)00373-6

Identifiers

DOI

1 reference

27 November 2017

1 reference